Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, ras, or myc function and involves the induction of apoptosis

S. Balachandran, M. Porosnicu, Glen N Barber

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

We have recently shown that vesicular stomatitis virus (VSV) exhibits potent oncolytic activity both in vitro and in vivo (S. Balachandran and G. N. Barber, IUBMB Life 50:135-138, 2000). In this study, we further demonstrated, in vivo, the efficacy of VSV antitumor action by showing that tumors that are defective in p53 function or transformed with myc or activated ras are also susceptible to viral cytolysis. The mechanism of viral oncolytic activity involved the induction of multiple caspase-dependent apoptotic pathways was effective in the absence of any significant cytotoxic T-lymphocyte response, and occurred despite normal PKR activity and eIF2α phosphorylation. In addition, VSV caused significant inhibition of tumor growth when administered intravenously in immunocompetent hosts. Our data indicate that VSV shows significant promise as an effective oncolytic agent against a wide variety of malignant diseases that harbor a diversity of genetic defects.

Original languageEnglish
Pages (from-to)3474-3479
Number of pages6
JournalJournal of Virology
Volume75
Issue number7
DOIs
StatePublished - Mar 31 2001

Fingerprint

Vesiculovirus
Vesicular Stomatitis
apoptosis
Apoptosis
Viruses
neoplasms
Neoplasms
cytolysis
cytotoxic T-lymphocytes
caspases
genetic disorders
Cytotoxic T-Lymphocytes
Caspases
phosphorylation
Phosphorylation
Growth

ASJC Scopus subject areas

  • Immunology

Cite this

Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, ras, or myc function and involves the induction of apoptosis. / Balachandran, S.; Porosnicu, M.; Barber, Glen N.

In: Journal of Virology, Vol. 75, No. 7, 31.03.2001, p. 3474-3479.

Research output: Contribution to journalArticle

@article{193a20d69626479f9f789f368081f3df,
title = "Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, ras, or myc function and involves the induction of apoptosis",
abstract = "We have recently shown that vesicular stomatitis virus (VSV) exhibits potent oncolytic activity both in vitro and in vivo (S. Balachandran and G. N. Barber, IUBMB Life 50:135-138, 2000). In this study, we further demonstrated, in vivo, the efficacy of VSV antitumor action by showing that tumors that are defective in p53 function or transformed with myc or activated ras are also susceptible to viral cytolysis. The mechanism of viral oncolytic activity involved the induction of multiple caspase-dependent apoptotic pathways was effective in the absence of any significant cytotoxic T-lymphocyte response, and occurred despite normal PKR activity and eIF2α phosphorylation. In addition, VSV caused significant inhibition of tumor growth when administered intravenously in immunocompetent hosts. Our data indicate that VSV shows significant promise as an effective oncolytic agent against a wide variety of malignant diseases that harbor a diversity of genetic defects.",
author = "S. Balachandran and M. Porosnicu and Barber, {Glen N}",
year = "2001",
month = "3",
day = "31",
doi = "10.1128/JVI.75.7.3474-3479.2001",
language = "English",
volume = "75",
pages = "3474--3479",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, ras, or myc function and involves the induction of apoptosis

AU - Balachandran, S.

AU - Porosnicu, M.

AU - Barber, Glen N

PY - 2001/3/31

Y1 - 2001/3/31

N2 - We have recently shown that vesicular stomatitis virus (VSV) exhibits potent oncolytic activity both in vitro and in vivo (S. Balachandran and G. N. Barber, IUBMB Life 50:135-138, 2000). In this study, we further demonstrated, in vivo, the efficacy of VSV antitumor action by showing that tumors that are defective in p53 function or transformed with myc or activated ras are also susceptible to viral cytolysis. The mechanism of viral oncolytic activity involved the induction of multiple caspase-dependent apoptotic pathways was effective in the absence of any significant cytotoxic T-lymphocyte response, and occurred despite normal PKR activity and eIF2α phosphorylation. In addition, VSV caused significant inhibition of tumor growth when administered intravenously in immunocompetent hosts. Our data indicate that VSV shows significant promise as an effective oncolytic agent against a wide variety of malignant diseases that harbor a diversity of genetic defects.

AB - We have recently shown that vesicular stomatitis virus (VSV) exhibits potent oncolytic activity both in vitro and in vivo (S. Balachandran and G. N. Barber, IUBMB Life 50:135-138, 2000). In this study, we further demonstrated, in vivo, the efficacy of VSV antitumor action by showing that tumors that are defective in p53 function or transformed with myc or activated ras are also susceptible to viral cytolysis. The mechanism of viral oncolytic activity involved the induction of multiple caspase-dependent apoptotic pathways was effective in the absence of any significant cytotoxic T-lymphocyte response, and occurred despite normal PKR activity and eIF2α phosphorylation. In addition, VSV caused significant inhibition of tumor growth when administered intravenously in immunocompetent hosts. Our data indicate that VSV shows significant promise as an effective oncolytic agent against a wide variety of malignant diseases that harbor a diversity of genetic defects.

UR - http://www.scopus.com/inward/record.url?scp=0035109180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035109180&partnerID=8YFLogxK

U2 - 10.1128/JVI.75.7.3474-3479.2001

DO - 10.1128/JVI.75.7.3474-3479.2001

M3 - Article

C2 - 11238874

AN - SCOPUS:0035109180

VL - 75

SP - 3474

EP - 3479

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 7

ER -